X

Blog

QualityStocksNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Looking to Solve Medical Challenge in Immune Responses

Aditxt (NASDAQ: ADTX) has sought to address a medical conundrum: approximately 50% of all transplanted organs are rejected by the…

QualityStocks

QualityStocksNewsBreaks – Friendable Inc.’s (FDBL) 360-Degree Offering Promoting Artists’ Independence, Revenue Generation

Friendable (OTC: FDBL), a mobile technology and marketing company, announced its acquisition of Artist Republik and FeaturedX in January 2022,…

QualityStocks

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Positioning Berubicin Clinical Development Program for Success

CNS Pharmaceuticals (NASDAQ: CNSP) is currently recruiting patients for a phase II study evaluating the efficacy and safety of Berubicin,…

QualityStocks

More Than Just Energy: EverGen Infrastructure Corp.’s (TSX.V: EVGN) (OTCQB: EVGIF) Renewable Fuels Reducing Greenhouses Gases and Landfill Use

Canada has a goal to reduce greenhouse gas emissions by as much as 45% beneath 2005 levels and 30% below…

QualityStocks

The New York Cannabis and Hemp Convention to Boost the Growing Local Markets

Businesses, entrepreneurs, advocates, patients, investors, educators, and consumers, are invited to attend the NECANN Convention, a physical event being held…

QualityStocks

Hillcrest Energy Technologies Ltd.’s (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA) Currie: Tomorrow is Today for Next-Generation Electric Vehicle

The $70-billion global power inverter market is expected to climb to $95 billion by 2028 Hillcrest has patented new inverter…

QualityStocks

GeoSolar Technologies Inc. Empowers Colorado Homes and Businesses with Energy Independence, Eyes Nationwide Expansion

Fossil fuel-dependent households face up to 94% future cost increases GeoSolar’s patent pending SmartGreen(TM) system offers energy independence, eliminates CO2…

QualityStocks

Lexaria Bioscience Corp. (NASDAQ: LEXX) Inches Closer to DehydraTECH-CBD FDA Evaluation Following Successful Dosing in Multi-Week HYPER-H21-4 Human Clinical Study

Lexaria just completed dosing for its HYPER H21-4 human clinical study that dosed 64 patients aged between 40 and 70…

QualityStocks

QualityStocksNewsBreaks – SPYR Inc. (SPYR) Micro-Tracker, Asset-Tracking News Featured in Emerging Markets Report

SPYR (OTCQB: SPYR), a diversified technology company developing products and leveraging the Internet of Things (“Iot”) for consumer use and large-scale…

QualityStocks

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures Approval to Manufacture Hemp-Derived CBD Products in South Easton Facility

Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and…

QualityStocks